Lately, Ministry of Industry and Information Technology of the P. R. China released the ranking of pharmaceutical enterprises of 2011 on its homepage. The operating revenue of YRPG ranked the first place. It was the third time for YRPG to rank the first place among the pharmaceutical enterprises. The total profits of YRPG ranked the fifth.
In prime operating revenue, the top 10 enterprises were Yangtze River Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Shanghai Pharmaceutical Group (Industrial Department), Harbin Pharmaceutical Group Holding Co., Ltd., Shijiazhuang Pharmaceutical Group Co., Ltd., Tasly Pharmaceutical Group Co., Ltd., Wego Holding Co., Ltd., Yunnan Baiyao Group Co., Ltd., China National Pharmaceutical Group Corporation and Guangzhou Pharmaceuticals Corporation.
In total profits, the top 10 enterprises were China National Pharmaceutical Group Corporation, Wego Holding Co., Ltd., Shanghai Pharmaceutical Group, Shandong Buchang Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, Xinhecheng Group Holding Co., Ltd., Harbin Pharmaceutical Group Holding Co., Ltd., Yunnan Baiyao Group Co., Ltd., Tasly Pharmaceutical Group Co., Ltd. and Qilu Pharmaceutical Co., Ltd.
The chart was made by Consumption Industry Department of Ministry of Industry and Information Technology by integrating the three major factors of total capital, prime operating revenue and total profits. The enterprise ranking was based on the industrial business entity. As for the business entities on the consolidated statements, the ranking was based on the consolidated statements and the subsidiaries under the consolidated scope did not participate in the ranking.